Overseas doctors will remain ‘crucial’
Attracting skilled overseas-trained doctors to the UK will remain “crucial”, despite plans to train more healthcare staff here, the doctors’ … Read More “Overseas doctors will remain ‘crucial’”
Attracting skilled overseas-trained doctors to the UK will remain “crucial”, despite plans to train more healthcare staff here, the doctors’ … Read More “Overseas doctors will remain ‘crucial’”
Tens of thousands more women at increased risk of breast cancer could now benefit from a proven risk-reducing drug on … Read More “Tens of thousands of women set to benefit”
PART TWO Organisational Performance (OP) Designed to allow aspiring and existing leaders and managers to understand and promote change by … Read More “AMSPAR PROFESSIONAL STANDARDS”
Vaccination regulations adopted due to the Covid pandemic will be extended until 2026 following a Government consultation. Among other things, … Read More “Pandemic vaccination regulations”
PART TWO Organisational Performance (OP) Designed to allow aspiring and existing leaders and managers to understand and promote change by … Read More “AMSPAR PROFESSIONAL STANDARDS”
Practices in England are being contacted about GP seniority payments calculations dating back 10 years and could be asked to … Read More “Practices asked to repay”
The support on offer for patients at their GP practice is expanding, thanks to thousands more healthcare staff working in … Read More “Expanded NHS support available for patients”
PART TWO Organisational Performance (OP) Designed to allow aspiring and existing leaders and managers to understand and promote change by … Read More “AMSPAR Professional Standards”
In response to the Care Quality Commission (CQC) State of Care report, Professor Sir Stephen Powis, NHS National Medical Director, said: … Read More “NHS England responds to CQC State of Care report”
Hundreds of people with an aggressive type of blood cancer, known as diffuse large B-cell lymphoma (DLBCL) are set to … Read More “New treatment that could prove curative for blood cancer”